Neff MD, Hong Kan PhD, et al
A pilot study (study 3: 0.3 and 3 mg/kg, orally once daily) and a complete varied dose study (study 4: 0.1, 0.5, 2.5 and 12.5 mg/kg, oral once daily) in ob/ob for 30 days
When to Call Your Doctor You should contact your healthcare provider right away if you experience: Severe stomach pain Persistent nausea or vomiting Signs of dehydration Yellowing of the skin or eyes (jaundice) Unusual swelling or allergic reaction Trouble swallowing or a lump in the neck Final Thoughts: Is Mounjaro Safe
Tirzepatide Tirzepatide is a dual-action peptide
PBAC's move responds to Health Minister Mark Butler's March request for advice on equitable GLP-1 access, balancing benefits against budget strains from high demand
Current concepts, opportunities, and challenges of gut microbiome-based personalized medicine in nonalcoholic fatty liver disease